OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: Christopher Hulme

1 Projects | 1 Researchers | $99,964 Invested

2017

University of Arizona

Christopher Hulme, PhD

Optimization of selective DYRK1A inhibitors as a treatment for AD

  • Funding Amount: $99,964
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Tau
  • Status: Closed